SP Robotic Versus VATS Anatomical Pulmonary Resection for Patients With NSCLC
Conditions: Robotics; Lung Cancer Interventions: Procedure: Single-port robotic-assisted thoracic surgery; Procedure: Single-port video-assisted thoracoscopic surgery Sponsors: Korea University Guro Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Interest of Intensive Postoperative Rehabilitation Following Minimally Invasive Lung Resection
Conditions: Lung Cancer Interventions: Other: rehabilitation Sponsors: University Hospital, Rouen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Support for Cancer Patients Awaiting News
Conditions: Lung Cancer Interventions: Behavioral: Adapted Stress Management Program; Behavioral: Enhanced Usual Care Sponsors: Hackensack Meridian Health; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
Conditions: Pancreatic Adenocarcinoma; Cholangiocarcinoma; Lung Cancer; Stomach Cancer; Esophageal Carcinoma; Breast Cancer Interventions: Drug: Paclitaxel Polymeric Micelles for Injection Sponsors: Liu Huang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)
Conditions: Non-Small-Cell Lung Cancer Interventions: Drug: Golidocitinib; Drug: Sintilimab; Drug: platinum doublet chemotherapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Dizal Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
Conditions: Non-small Cell Lung Cancer Interventions: Procedure: Operable Sponsors: Jiangsu Cancer Institute& Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
The Effect of 360 ° Virtual Reality Movies on Fear and Anxiety
Conditions: Fear; Anxiety; Breast Cancer; Lung Cancer; Prostate Cancer; Head and Neck Cancer; Brain Tumor Interventions: Other: Questionnaire: SPIRIT; Other: Questionnaire: HADS; Other: Questionnaire: QSC-R23; Other: General questions; Other: Clinical data collected Sponsors: Maastricht Radiation Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
GPC3/Mesothelin-CAR- γδT Cells Against Cancers
Conditions: Pancreas Cancer; Lung Cancer; Liver Cancer; Mesothelioma; CAR-T Cell Therapy; Solid Tumor, Adult Interventions: Biological: Cell therapy for solid tumors Sponsors: Second Affiliated Hospital of Guangzhou Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
A Study to Investigate the Family History of Cancer in Patients With Non-small Cell Lung Cancer (FAHIC - Lung).
Conditions: Non Small Cell Lung Cancer Interventions: Other: study questionnaire to investigate family history Sponsors: Fondazione Policlinico Universitario Campus Bio-Medico; A.O.U. Citt à della Salute e della Scienza - Molinette Hospital; IRCCS San Raffaele Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure ：Phase I/II
Conditions: Non Small Cell Lung Cancer Interventions: Drug: Sunvozertinib; Drug: Chemotherapy Sponsors: Sichuan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations
Conditions: Lung Cancer Interventions: Drug: Osimertinib; Drug: Cisplatin or Carboplatin; Pemetrexed or Paclitaxel; Drug: Radiation Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung Cancer
Conditions: Lung Cancer; Healthy Human Interventions: Drug: 68Ga-A3 Sponsors: Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study.
Conditions: Non-small Cell Lung Cancer; PDL1 Gene Mutation Interventions: Drug: Serplulimab Sponsors: Zhejiang Cancer Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Conditions: Lung Carcinoma Interventions: Other: Educational Intervention; Other: Educational Intervention; Other: Exercise Intervention; Other: Medical Device Usage and Evaluation; Other: Physical Performance Testing; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
PEMBRO-K : Evaluation of Pembrolizumab Therapeutic Pharmacological Monitoring Benefit in Non-small Cell Bronchopulmonary Cancer (NSCLC)
Conditions: Non Small Cell Lung Cancer Sponsors: University Hospital, Angers Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
